Watermark
  Back to Search Results

BGB-3111-308

Recruiting

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

Ask to Join

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-308

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT05100862

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2022-502548-12-00

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20232545

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents